These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 20878498
1. Unusual presentation of gastrointestinal stromal tumor with early cerebral involvement. Janku F, Kidney D, Coyne J. Ir J Med Sci; 2011 Sep; 180(3):765-6. PubMed ID: 20878498 [Abstract] [Full Text] [Related]
2. CT scan is not everything in the evaluation of a patient with gastrointestinal tumors (GIST) under imatinib therapy. Wang CM, Fu H, Zhao GF, Wang J, Shi YQ. Pathol Oncol Res; 2012 Oct; 18(4):1095-7. PubMed ID: 21927980 [No Abstract] [Full Text] [Related]
3. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571). Demetri GD. Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773 [Abstract] [Full Text] [Related]
8. Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate. Joensuu H, De Braud F, Coco P, De Pas T, Putzu C, Spreafico C, Bono P, Bosselli S, Jalava T, Laurent D, Casali PG. Ann Oncol; 2008 Jan; 19(1):173-7. PubMed ID: 17698976 [Abstract] [Full Text] [Related]
9. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors. De Giorgi U, Aliberti C, Benea G, Conti M, Marangolo M. Clin Cancer Res; 2005 Sep 01; 11(17):6171-6. PubMed ID: 16144917 [Abstract] [Full Text] [Related]
10. Pathological complete response in advanced gastrointestinal stromal tumor after imatinib therapy. Melichar B, Voboril Z, Nozicka J, Ryska A, Urminská H, Vanecek T, Michal M. Intern Med; 2005 Nov 01; 44(11):1163-8. PubMed ID: 16357454 [Abstract] [Full Text] [Related]
11. New strategies for treating GIST when imatinib fails. Boyar MS, Taub RN. Cancer Invest; 2007 Aug 01; 25(5):328-35. PubMed ID: 17661208 [Abstract] [Full Text] [Related]
13. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors. Nishida T, Doi T, Naito Y. Expert Opin Pharmacother; 2014 Oct 01; 15(14):1979-89. PubMed ID: 24990162 [Abstract] [Full Text] [Related]
19. Complete remission of recurrent gastrointestinal stromal tumors after treatment with imatinib: report of a case. Kobayashi M, Okamoto K, Nakatani H, Okabayashi T, Namikawa T, Ichikawa K, Kitagawa H, Araki K. Surg Today; 2006 Apr 01; 36(8):727-32. PubMed ID: 16865518 [Abstract] [Full Text] [Related]
20. Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1. Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, Lee H, Park JH, Kim HC, Kim JS, Kang YK. Dig Dis Sci; 2006 Jun 01; 51(6):1043-6. PubMed ID: 16865565 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]